Brought to you by 
Series D brings in $10mm for Kona Medical
08 Nov 2013
Executive Summary
Morningside Group was the sole investor in Kona Medical Inc.’s $10mm Series D venture round. The funds will be used to market Kona’s Surround Sound renal denervation system in China. The product uses ultrasound to treat nerves leading to and from the kidney, ultimately lowering blood pressure in drug-resistant hypertension patients.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Series D brings in $10mm for Kona Medical
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice